BEAM
#1719
Beam Therapeutics Inc. - Common Stock
29.3 2 USD
-0.04%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.81%
Monthly Change
+12.64%
6 month change
+7.05%
Year Change
+81.10%
Previous Close
30.4 8
Open
29.3 2
Low
29.3 2
High
29.3 2
Volume
155
Financials
- Market Capitalization 3.03 B
- Employee 540
- Founded 2017
- CEO John Evans
- Website www.beamtx.com
- Headquarter Delaware, United States
- FIGI BBG00KXC8646
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-34.22
Price to sales ratio
19.62
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1703 |  IRON Disc Medicine, Inc. - Common Stock | 80.03 USD | -3.05% | +0.19% | +7.90% | +34.46% | 3.07 B USD | ||
| 1704 |  CLDX Celldex Therapeutics, Inc. - Common Stock | 39.12 USD | -3.31% | -2.59% | +4.99% | +43.61% | 3.07 B USD | ||
| 1727 |  ARQT Arcutis Biotherapeutics, Inc. - Common stock | 23.78 USD | -4.38% | -4.11% | -15.10% | +53.82% | 2.99 B USD | ||
| 1741 |  ZLAB Zai Lab Limited - American Depositary Shares | 26.08 USD | -2.76% | +2.35% | +42.67% | -2.29% | 2.93 B USD |
Frequently asked questions about Beam Therapeutics Inc. Common Stock
What is the Beam Therapeutics Inc. Common Stock stock price today?
The current price of Beam Therapeutics Inc. Common Stock (BEAM) is 29.32. Over the past 24 hours, the stock has changed by -3.81%. Follow the BEAM chart for real-time price dynamics.
What is the stock ticker of Beam Therapeutics Inc. Common Stock?
Beam Therapeutics Inc. Common Stock trades under the ticker BEAM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Beam Therapeutics Inc. Common Stock stock going up?
BEAM has changed by +0.34% over the last week, +12.64% over the last month, and +81.10% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Beam Therapeutics Inc. Common Stock?
Beam Therapeutics Inc. Common Stock currently has a market capitalization of 3.03 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
Does Beam Therapeutics Inc. Common Stock release financial reports?
Yes. You can track Beam Therapeutics Inc. Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What were Beam Therapeutics Inc. Common Stock earnings last quarter?
Last quarter, Beam Therapeutics Inc. Common Stock reported earnings of -1.18 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Beam Therapeutics Inc. Common Stock revenue for the last quarter?
Beam Therapeutics Inc. Common Stock reported quarterly revenue of 490 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Beam Therapeutics Inc. Common Stock net income for the last quarter?
Beam Therapeutics Inc. Common Stock reported net income of -122.68 M for the last quarter. The previous quarter showed -94.32 M, which means net income changed by -30.07%.
How many employees does Beam Therapeutics Inc. Common Stock have?
As of the latest available data, Beam Therapeutics Inc. Common Stock has 540 employees. Workforce size can provide additional context about the company's scale and operations.
What is Beam Therapeutics Inc. Common Stock EBITDA?
Beam Therapeutics Inc. Common Stock EBITDA is -121.14 M, and its EBITDA margin is -24.72 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Beam Therapeutics Inc. Common Stock stock?
You can buy Beam Therapeutics Inc. Common Stock (BEAM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Beam Therapeutics Inc. Common Stock stock?
Investing in Beam Therapeutics Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BEAM chart and related analysis on metatrader.com as part of your research.